Clinical Trials in A Coruña, A Coruña
8 recruiting
Showing 1–8 of 8 trials
Recruiting
Phase 3
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Non-small Cell Lung CancerNSCLCNSCLC (Advanced Non-small Cell Lung Cancer)+2 more
Revolution Medicines, Inc.420 enrolled129 locationsNCT06881784
Recruiting
Phase 3
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Heart FailureHeart Failure With Reduced Ejection Fraction
Cytokinetics1,800 enrolled183 locationsNCT06736574
Recruiting
Pathological Response After Neoadjuvant Treatment on NSCLC
Stage IIIA Non-small Cell Lung Cancer
Fundación GECP150 enrolled17 locationsNCT05167487
Recruiting
Phase 2
A Study of SPY072 in Rheumatic Disease
Rheumatoid ArthritisPsoriatic ArthritisRheumatic Diseases+5 more
Spyre Therapeutics, Inc.285 enrolled41 locationsNCT07148414
Recruiting
Phase 2
Study to Evaluate the Efficacy of Axicabtagene Ciloleucel in Patients With Late Relapse of Diffuse Large B-Cell Lymphoma
Diffuse Large B Cell Lymphoma
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea45 enrolled15 locationsNCT07254754
Recruiting
Phase 2
Encorafenib and biNimetinib Followed by CEmiplimab and FiAnLimab in Patients With BRAF Mutant melanOma and Symptomatic Brain Metastases
Melanoma BRAF V600E/K MutatedMelanoma and Brain Metastases
Grupo Español Multidisciplinar de Melanoma33 enrolled18 locationsNCT06887088
Recruiting
Phase 2
PLUG-IN: Pembrolizumab Combined With Enfortumab Vedotin for Advanced Melanoma Patients
Melanoma
Grupo Español Multidisciplinar de Melanoma60 enrolled13 locationsNCT06906822
Recruiting
The Head and Neck Registry of the European Reference Network on Rare Adult Solid Cancers
Head and Neck CancerSalivary Gland CancerNasopharynx Cancer+2 more
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano13,600 enrolled12 locationsNCT05483374